The miR‐302/367 cluster: Aging, inflammation, and cancer

Author:

Li Zhou1,Duan Yan2,Yan Shaofu1,Zhang Yao1,Wu Yunxia13ORCID

Affiliation:

1. Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials Shanxi Medical University School and Hospital of Stomatology Taiyuan Shanxi Province China

2. Department of Stomatology Shanxi Provincial People's Hospital Taiyuan Shanxi Province China

3. Department of Stomatology First Hospital of Shanxi Medical University Taiyuan Shanxi Province China

Abstract

AbstractMicroRNAs (miRNAs) are a class of noncoding RNAs that occupy a significant role in biological processes as important regulators of intracellular homeostasis. First, we will discuss the biological genesis and functions of the miR‐302/367 cluster, including miR‐302a, miR‐302b, miR‐302c, miR‐302d, and miR‐367, as well as their roles in physiologically healthy tissues. The second section of this study reviews the progress of the miR‐302/367 cluster in the treatment of cancer, inflammation, and diseases associated with aging. This cluster's aberrant expression in cells and/or tissues exhibits similar or different effects in various diseases through molecular mechanisms such as proliferation, apoptosis, cycling, drug resistance, and invasion. This article also discusses the upstream and downstream regulatory networks of miR‐302/367 clusters and their related mechanisms. Particularly because studies on the upstream regulatory molecules of miR‐302/367 clusters, which include age‐related macular degeneration, myocardial infarction, and cancer, have become more prevalent in recent years. MiR‐302/367 cluster can be an important therapeutic target and the use of miRNAs in combination with other molecular markers may improve diagnostic or therapeutic capabilities, providing unique insights and a more dynamic view of various diseases. It is noted that miRNAs can be an important bio‐diagnostic target and offer a promising method for illness diagnosis, prevention, and treatment.

Funder

ShanXi Science and Technology Department

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3